ArticleArteriosclerosis, thrombosis, and vascular biology2026
Extracellular Mitochondria Mediate Endothelial Injury After Traumatic Brain Injury.
Article in Arteriosclerosis, thrombosis, and vascular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Circulating Extracellular Mitochondria Perpetuate Endothelial Damage via Cardiolipin-Mediated Mitophagic Overload.Arteriosclerosis, thrombosis, and vascular biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLocal and systemic endothelial dysfunction following traumatic brain injury (TBI) results in secondary cerebral and pulmonary edema, tissue ischemia, and inflammation. However, the underlying mechanism of the endothelial dysfunction beyond the site of the primary trauma remains poorly understood. Morphologically intact and metabolically active extracellular mitochondria (exMt) accounted for 55.2% of brain-derived extracellular vesicles found in the peripheral blood of mice subjected to severe TBI. This observation led us to investigate the role of exMt in TBI-induced secondary endothelial injury.
methodsWe measured circulating exMt in patients with TBI and mice subjected to TBI and examined the effects of exMt on endothelial cells in vitro and in vivo. Mechanistic studies involved evaluating Cavin-1-dependent endocytosis of exMt and its downstream effects on endothelial cells, including mitophagy activation, lysosomal dysfunction, and apoptosis. The findings were validated in Cavin-1 knockdown endothelial cells and Cavin-1-deficient mice.
resultsHere, we report the detection of high levels of exMt in the peripheral blood samples from patients with TBI. These circulating exMt bound to and were endocytosed by endothelial cells via a Cavin-1-dependent pathway. exMt activated endothelial cells, caused vascular leakage, and promoted an inflammatory response in vitro. Furthermore, noninjured mice infused with exMt developed similar changes in the brain and lungs. exMt endocytosed by endothelial cells activated mitophagy and promoted the formation of mitophagosomes but impaired lysosomal function, leading to endothelial cell apoptosis.
conclusionsResults from this study demonstrate a novel subcellular mechanism for exMt-induced endothelial dysfunction during acute TBI.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.